Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02474940 · ClinicalTrials.gov registry record · NA

MS Symptom Management Study

A NA study of Multiple Sclerosis and Chronic Pain, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT02474940 is a NA study of Multiple Sclerosis and Chronic Pain that has completed, run by University of Washington. The registered enrollment target is 37 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02474940, a NA study of Multiple Sclerosis and Chronic Pain, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

People with Multiple Sclerosis (MS) often have pain and/or fatigue. Unfortunately, available treatments provide inadequate relief for the majority of these individuals. There remains an urgent need for additional treatment options for MS-related symptoms. The purpose of this study is to see if alternative treatments that involve self-hypnosis training, neurofeedback training and/or mindfulness meditation training, or a combination of some of these treatments can help decrease pain and fatigue in people with MS. A subject must have a diagnosis of MS, have chronic pain and/or fatigue, and be at least 18 years old to participate, among other criteria.

Interventions

  • BEHAVIORAL Intervention #1
  • BEHAVIORAL Intervention #2
  • BEHAVIORAL Intervention #3

Study Locations (1)

Washington

  • University of Washington, Ninth and Jefferson Building - Seattle

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2015-06
Est. Completion 2016-11
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT02474940

The ClinicalTrials.gov registry entry for NCT02474940 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 3 interventions - of which Intervention #1 is the first listed.

NCT02474940 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02474940 about?

NCT02474940 is a clinical study titled "MS Symptom Management Study". People with Multiple Sclerosis (MS) often have pain and/or fatigue. Unfortunately, available treatments provide inadequate relief for the majority of these individuals. There remains an urgent need for additional treatment options for MS-related symptoms. The purpose of this study is to see if alter...

What is the current status of trial NCT02474940?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2015-06. Estimated completion is 2016-11.

What conditions does trial NCT02474940 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Chronic Pain, Fatigue.

What interventions are being tested in trial NCT02474940?

The interventions under investigation include: Intervention #1 (BEHAVIORAL), Intervention #2 (BEHAVIORAL), Intervention #3 (BEHAVIORAL).

Who is sponsoring clinical trial NCT02474940?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02474940 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.